Strategies and challenges for the next generation of therapeutic antibodies

被引：636
|
作者：
Beck, Alain [1 ]
Wurch, Thierry [1 ]
Bailly, Christian [1 ]
Corvaia, Nathalie [1 ]
机构：
[1] CIPF, F-74160 St Julien En Genevois, France
来源：
NATURE REVIEWS IMMUNOLOGY | 2010年 / 10卷 / 05期
关键词：
MONOCLONAL-ANTIBODIES; CANCER-THERAPY; COLORECTAL-CANCER; DRUG; GLYCOSYLATION; BINDING; MOUSE; IDENTIFICATION; OPTIMIZATION; SPECIFICITY;
D O I：
10.1038/nri2747
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Antibodies and related products are the fastest growing class of therapeutic agents. By analysing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, we can gain insights into the successful strategies used by pharmaceutical companies so far to bring innovative drugs to the market. Many challenges will have to be faced in the next decade to bring more efficient and affordable antibody-based drugs to the clinic. Here, we discuss strategies to select the best therapeutic antigen targets, to optimize the structure of IgG antibodies and to design related or new structures with additional functions.
引用
收藏
页码：345 / 352
页数：8
相关论文
共 50 条
  • [31] Plant glycoengineering for designing next-generation vaccines and therapeutic proteins
    Strasser, Richard
    BIOTECHNOLOGY ADVANCES, 2023, 67
  • [32] VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy
    Shekari, Najibeh
    Shanehbandi, Dariush
    Kazemi, Tohid
    Zarredar, Habib
    Baradaran, Behzad
    Jalali, Seyed Amir
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [33] Application of Next-Generation Sequencing in Neurodegenerative Diseases: Opportunities and Challenges
    Shademan, Behrouz
    Biray Avci, Cigir
    Nikanfar, Masoud
    Nourazarian, Alireza
    NEUROMOLECULAR MEDICINE, 2021, 23 (02) : 225 - 235
  • [34] Improving small molecule virtual screening strategies for the next generation of therapeutics
    Wingert, Bentley M.
    Camacho, Carlos J.
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2018, 44 : 87 - 92
  • [35] Bioprocess Challenges in Purification of Therapeutic Protein Charge Variants
    Gupta, Tarun
    Kumar, Anuj
    Seshadri, Sriram
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2023, 28 (04) : 493 - 506
  • [36] Risk-Based Strategies for the Next Generation of Maintenance and Inspection Programs
    Conachey, Robert
    Serratella, Christopher M.
    Wang, Ge
    WMU JOURNAL OF MARITIME AFFAIRS, 2008, 7 (01) : 151 - 173
  • [37] Next-Generation Strategies for Hereditary Colorectal Cancer Risk Assessment
    Yurgelun, Matthew B.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (05) : 388 - U21
  • [38] Strategies for detection, measurement and characterization of unwanted antibodies induced by therapeutic biologicals
    Wadhwa, M
    Bird, C
    Dilger, P
    Gaines-Das, R
    Thorpe, R
    JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 278 (1-2) : 1 - 17
  • [39] Next-generation bNAbs for HIV-1 cure strategies
    Schriek, A. I.
    Aldon, Y. L. T.
    van Gils, M. J.
    de Taeye, S. W.
    ANTIVIRAL RESEARCH, 2024, 222
  • [40] Therapeutic monoclonal antibodies in oncology
    Bouzid, K.
    Bedairia, N.
    Marty, M.
    PATHOLOGIE BIOLOGIE, 2012, 60 (04): : 223 - 228
12345